Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI-enhanced detection of prostate cancer
0
Zitationen
1
Autoren
2026
Jahr
Abstract
Prostate cancer poses a pressing public health challenge with an increasing elderly population in whom prostate cancer-specific mortality is highest. For the diagnosis of prostate cancer, magnetic resonance imaging (MRI) scans are recommended, leading to an increasing demand and a need to use current diagnostic resources more efficiently. This thesis explored an AI-enhanced diagnostic pathway to handle the increasing demand for prostate cancer diagnosis. The focus was on evaluating AI-enhanced lesion detection and AI-based reconstruction of accelerated MRI, assessing the effectiveness compared to conventional methods, and discussing the potential impact on clinical practice.<br/><br/>This thesis demonstrates the potential of AI to reduce MRI scan time and assist radiologists in assessing prostate MRI. The proposed prostate cancer diagnostic pathway could reduce MRI scan time by up to 71% without significantly compromising diagnostic quality. Furthermore, AI could reduce the radiologists’ workload by up to 20%, which might increase with continued improvements in AI performance. The use of AI for prostate cancer detection was also accepted by patients, especially with AI performances approaching expert level. <br/><br/>These findings indicate an AI-enhanced diagnostic pathway that benefits the patient, society, and healthcare professionals. The proposed pathway could potentially handle the increasing demand for prostate cancer diagnosis, but before clinical deployment, prospective studies are needed to validate the generalization of the findings in this thesis.
Ähnliche Arbeiten
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 · 5.713 Zit.
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 · 5.473 Zit.
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 · 5.258 Zit.
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 · 4.560 Zit.
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 · 4.506 Zit.